Cargando…
Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers
BACKGROUND: Observational studies often infer hepatic de novo lipogenesis (DNL) by measuring circulating fatty acid (FA) markers; however, it remains to be elucidated whether these markers accurately reflect hepatic DNL. OBJECTIVES: We investigated associations between fasting hepatic DNL and propos...
Autores principales: | Rosqvist, Fredrik, McNeil, Catriona A, Pramfalk, Camilla, Parry, Sion A, Low, Wee Suan, Cornfield, Thomas, Fielding, Barbara A, Hodson, Leanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367991/ https://www.ncbi.nlm.nih.gov/pubmed/30721918 http://dx.doi.org/10.1093/ajcn/nqy304 |
Ejemplares similares
-
Using total plasma triacylglycerol to assess hepatic de novo lipogenesis as an alternative to VLDL triacylglycerol
por: Hodson, Leanne, et al.
Publicado: (2020) -
Sex Differences in Hepatic De Novo Lipogenesis with Acute Fructose Feeding
por: Low, Wee Suan, et al.
Publicado: (2018) -
Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
por: Green, Charlotte J, et al.
Publicado: (2020) -
The influence of nutritional state on the fatty acid composition of circulating lipid fractions: implications for their use as biomarkers of dietary fat intake
por: Parry, Sion A., et al.
Publicado: (2021) -
Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis
por: Green, Charlotte J, et al.
Publicado: (2022)